Join us for a free, P.A.C.E. and CERP accredited educational seminar:
The Clinical Impact of Blood Glucose Monitoring System
Accuracy in Critically Ill Patients
A clinician’s treatment of critically ill patients can be undermined by inaccurate point-of-care (POC) glucose meter results. Inaccurate results are most often caused by interferences related to patient physiology and exogenous substances like medications, therapeutics, and non-glucose sugars. Inaccurate glucose results put patients at risk for improper insulin dosing and missed hypoglycemic events, and have caused adverse events and even death.
Using peer-reviewed evaluations and case studies, our seminar examines the risks posed by interferences and sample selection to glucose meter accuracy, and how important accuracy is for the safety and outcomes of all hospitalized patients and especially critically ill patients.
Topics and Learning Objectives
Understand the clinical impact of POC glucose
meter accuracy on critically ill patients.
Describe how interferences lead to erroneous glucose
results, improper patient treatment, and adverse events.
Examine case studies of patient adverse events caused
by interferences to POC glucose meters.
Discuss the only glucose meter to be FDA-cleared for use
with all hospitalized patients including critically ill.
Who should attend?
• POC coordinators
• Laboratory professionals • Risk managers
This seminar provides 2.5 contact hours for P.A.C.E. and CERP continuing education credits. P.A.C.E. is a registered trademark of the American Society for Clinical Laboratory Science. Nova Biomedical is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
Space is limited.
We look forward to seeing you there!